Final Analysis of a Trial of M72/AS01
Date
2019-Dec-19
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
BACKGROUND: Results of an earlier analysis of a trial of the M72/AS01
METHODS: From August 2014 through November 2015, we enrolled adults 18 to 50 years of age with
RESULTS: A total of 3575 participants underwent randomization, of whom 3573 received at least one dose of M72/AS01
CONCLUSIONS: Among adults infected with